Oral News and Research

RSS

LogicBio team to present data on preclinical effectiveness of GeneRide platform

LogicBio Therapeutics, Inc., a genetic medicine company founded to develop safe medicines with lasting therapeutic benefit for children with life-threatening diseases, today announced it will be presenting data on the company's technology and robust preclinical pipeline at the annual meeting of the American Society of Gene & Cell Therapy at the Hilton Chicago, from May 16-19, 2018.

14 May 2018

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.

14 May 2018

Oral drug reduces venous thromboembolism recurrence among cancer patients

Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.

11 May 2018

New combined risk score shows improved effectiveness in predicting stroke risk of Afib patients

Doctors know patients with atrial fibrillation are at a higher risk of having a stroke, and now a new study finds that integrating two separate clinical risk score models helps clinicians more accurately assess the stroke risk of patients with Afib.

11 May 2018

Oral antibiotic use may increase risk of developing kidney stones, shows study

Pediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones.

11 May 2018

HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

HORIBA UK Ltd, Medical announces a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

From HORIBA Medical 11 May 2018

Addressing Antimicrobial Resistance Through Industry

Antimicrobial resistance is currently one of the biggest health threats in the world. Gary Cohen and Steve Conly discuss the role of Becton, Dickinson & Co and other organizations in the private sector in combating the spread of resistance.

11 May 2018

New study links oral antibiotics with increased risk of kidney stones

The potential to promote antibiotic resistance in bacteria isn't the only reason to avoid using antibiotics when possible.

11 May 2018

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

Knopp Biosciences LLC today announced the publication of a report in the journal Blood that a Phase 2 study of dexpramipexole in hypereosinophilic syndromes met its co-primary endpoints.

10 May 2018

Poison ivy and poison oak can cause mild to severe allergic reactions

April showers might bring May flowers, but they also bring the arrival of troublesome plants such as poison ivy and poison oak that can cause mild to severe allergic reactions.

9 May 2018

Tradeshow Talks with Keneric Healthcare

Tradeshow Talks with Keneric Healthcare at Health GB 2018.

7 May 2018

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer treatment decisions, today announced the presentation of data supporting clinical use of the DecisionDx®-Melanoma test to inform sentinel lymph node biopsy (SLNB) recommendations.

7 May 2018

Researchers uncover role of ROS in clearing dead cells

If dead cells accumulate in the body, they can contribute to inflammation and pre-dispose individuals to multiple chronic inflammatory conditions such as rheumatoid arthritis, cardiovascular diseases, Crohn's disease or lupus by uncharacterized pathways.

7 May 2018

Women's perceptions of male attractiveness do not vary with hormone levels, shows study

Data from almost 600 participants show that women's perceptions of male attractiveness do not vary according to their hormone levels, in contrast with some previous research.

7 May 2018

$Study finds incidence of fractures in 15% of osteoporosis patients who take 'drug holidays'$

Study finds incidence of fractures in 15% of osteoporosis patients who take 'drug holidays'

Patients who take osteoporosis drugs for long periods typically are advised to temporarily discontinue the drugs to prevent rare but serious side effects to the jaw and thighs.

4 May 2018

New survey highlights need for BV awareness and education to ensure proper care

Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).

4 May 2018

Penn surgeons perform first ever robot-assisted complex spinal surgery for rare tumor removal

Noah Pernikoff is back to his life in New York City after becoming the first patient in the world to undergo a complex three-part, robotic-assisted surgery.

3 May 2018

Mother's milk found to have SWAT team of immune cells

Immune cells that are ready to take action against invaders like bacteria have been found in women's breast milk, researchers say.

3 May 2018

Nonsteroidal anti-inflammatory drug ranked to be most effective in treating knee OA

An estimated 45 percent of people are at risk of developing knee osteoarthritis (OA) in their lifetime. According to a network meta-analysis research article published in the May 1, 2018 issue of the Journal of the American Academy of Orthopaedic Surgeons, the nonsteroidal anti-inflammatory drug naproxen was ranked most effective in individual knee OA treatment for improving both pain and function, and is considered a relatively safe and low-cost treatment method.

2 May 2018

New studies could offer novel treatments for vision and eye conditions

Three new studies demonstrate research findings that could offer novel treatments for vision and eye conditions.

30 Apr 2018

Oral News and Research

LogicBio team to present data on preclinical effectiveness of GeneRide platform

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

Oral drug reduces venous thromboembolism recurrence among cancer patients

New combined risk score shows improved effectiveness in predicting stroke risk of Afib patients

Oral antibiotic use may increase risk of developing kidney stones, shows study

HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

Addressing Antimicrobial Resistance Through Industry

New study links oral antibiotics with increased risk of kidney stones

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

Poison ivy and poison oak can cause mild to severe allergic reactions

Tradeshow Talks with Keneric Healthcare

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Researchers uncover role of ROS in clearing dead cells

Women's perceptions of male attractiveness do not vary with hormone levels, shows study

Study finds incidence of fractures in 15% of osteoporosis patients who take 'drug holidays'

New survey highlights need for BV awareness and education to ensure proper care

Penn surgeons perform first ever robot-assisted complex spinal surgery for rare tumor removal

Mother's milk found to have SWAT team of immune cells

Nonsteroidal anti-inflammatory drug ranked to be most effective in treating knee OA

New studies could offer novel treatments for vision and eye conditions

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News